Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

por Moné, M. J., Pallocca, G., Escher, S. E., Exner, T., Herzler, M., Bennekou, S. Hougaard, Kamp, H., Kroese, E. D., Leist, Marcel, Steger-Hartmann, T., van de Water, B.
Publicado 2020

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells

por van Oosterwijk, J G, van Ruler, M A J H, Briaire-de Bruijn, I H, Herpers, B, Gelderblom, H, van de Water, B, Bovée, J V M G
Publicado 2013

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation

por van Miltenburg, M H A M, van Nimwegen, M J, Tijdens, I, Lalai, R, Kuiper, R, Klarenbeek, S, Schouten, P C, de Vries, A, Jonkers, J, van de Water, B
Publicado 2014

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

por Lombaerts, M, van Wezel, T, Philippo, K, Dierssen, J W F, Zimmerman, R M E, Oosting, J, van Eijk, R, Eilers, P H, van de Water, B, Cornelisse, C J, Cleton-Jansen, A-M
Publicado 2006

Best practices for the care of pregnant people living with TB

por Maugans, C., Loveday, M., Hlangu, S., Waitt, C., Van Schalkwyk, M., van de Water, B., Salazar-Austin, N., McKenna, L., Mathad, J. S., Kalk, E., Hurtado, R., Hughes, J., Eke, A. C., Ahmed, S., Furin, J.
Publicado 2023

Targeting survivin as a potential new treatment for chondrosarcoma of bone

por de Jong, Y, van Oosterwijk, J G, Kruisselbrink, A B, Briaire-de Bruijn, I H, Agrogiannis, G, Baranski, Z, Cleven, A H G, Cleton-Jansen, A-M, van de Water, B, Danen, E H J, Bovée, J V M G
Publicado 2016